Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Suspended × Radiation × CNS × Clear all

Phase

Status

Completed 56 Recruiting 20 Active not recruiting 19 Terminated 14 Unknown 8 Withdrawn 6 Not yet recruiting 4 Suspended 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 2 Gastrointestinal 2 Thoracic 1 CNS 1

Conditions

Brain Neoplasms 1

Interventions

Specimen Handling 4 Magnetic Resonance Spectroscopy 3 Bevacizumab 3 Biopsy 2 trametinib 1 selinexor 1 relatlimab 1 pembrolizumab 1 fluoromisonidazole 1 fludarabine phosphate 1 antineoplaston AS 2-1 1 antineoplaston A10 1 aldesleukin 1 X-Rays 1 Transcranial Magnetic Stimulation 1 Temozolomide 1 TPI-287 1 Surveys and Questionnaires 1 Surgical Procedures, Operative 1 Radiotherapy, Intensity-Modulated 1 Radiosurgery 1 Radiation 1 Nivolumab 1 Niacinamide 1 Niacin 1 Metformin 1 Mental Status and Dementia Tests 1 Magnetic Resonance Imaging 1 Lomustine 1 Lasers, Solid-State 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04084431 2024-01-05

RECARE

University Hospital Heidelberg

Phase NA Suspended

Brain Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡